The Rally Is Great, but It's Not All Rosy<br />By Rev Shark<br />RealMoney.com Contributor<br />4/22/2008 8:32 AM EDT <br /><br /><br />To emphasize only the beautiful seems to me to be like a mathematical system that only concerns itself with positive numbers. <br />-- Paul Klee<br /><br />The market action has certainly improved over the past week or so, but that doesn't mean we can assume that the worst is over. While we are presently enjoying a good rally attempt and have a good chance of some more upside in the near term, there are a number of concerns to contemplate. <br /><br />One of the biggest worries about the sustainability of the recent market strength is the lack of volume. Yesterday we saw the lightest volume of the year, and volume has been consistently below its 50-day moving average for over a month. <br /><br />Low volume doesn't mean stocks can't rally, but it does make the upside move less secure. Volume is fuel. It is an indication that big buyers are putting capital to work and are supporting the market. When stocks go up on higher volume, they have better technical support and are less likely to reverse their gains. <br /><br />The fact that volume has not increased as the market has turned up is an indication that there is a lack of confidence and a hesitancy to deploy capital. That doesn't mean we can't continue to rally but it makes the move less trustworthy. <br /><br />Another issue facing the market is leadership. We have had a two-tiered market for a while now. A few sectors such as energy, agriculture, mining and steel have had extremely strong momentum, with many of the strongest stocks in those groups making parabolic moves. <br /><br />Some of the big-cap technology stocks, like Apple (AAPL) , Research In Motion (RIMM) and Amazon (AMZN) have had better momentum, especially following the surprise earnings from Google (GOOG) , but they haven't taken a clear leadership role. <br /><br />Most of the rest of the market continues to flounder. Financials, for example, have had some rallies, but they remain in a downtrend and have yet to show signs that a bottom is near. <br /><br />The danger of this narrow and increasingly extended market leadership is obvious. It is especially worrisome because of the inflationary pressures that are inherent in strong energy and agriculture. At some point there will be a day of reckoning as those price increases weigh on the broader economy. <br /><br />A third worry is that there is little indication that our economic woes are at a bottom. Unemployment is growing, housing prices are falling and inflationary pressures are bubbling up. Many want to proclaim that the worst is behind us, but there is nothing to support that argument other than the triumph of hope over reality. <br /><br />The market is in better shape at the moment, and with some big earnings reports coming up, that may help to sustain the positive sentiment for now. Just don't get too comfortable with the idea that it is clear sailing to new highs. <br /><br />We have a little softness this morning as Texas Instruments (TXN) and Novellus (NVLS) issued slightly disappointing reports. Oil continues to hit record highs and we have housing data coming up. <br />-------------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: VLTR +12.1% (also upgraded to Outperform at Piper), ZRAN +11.2%, FOE +10.9%, WGOV +8.7%, CPO +6.4%, EAT +6.0%, JBLU +5.5%, BSX +5.1%, KCI +4.8%, MICC +4.4%, BTU +3.8%, LOGI +3.7%, NBR +3.4%, CE +3.2%, ALB +2.2%, LXK +2.0%, STLD +1.8%, T +1.6%, ARTC +1.3%, CR +1.2%, DD +1.0%, LMT +1.0%, HSC +1.0%... Other news: BMTI +10.1% (receives written communication from FDA confirming status of ongoing pivotal trial for GEM OS1), ICO +9.8% (still checking), FTEK +6.4% (Cramer makes positive comments on MadMoney), MHS +4.6% (Medco Health Solutions, UnitedHealth Group announce pharmacy services agreement; also upgraded to Buy at Jefferies and upgraded to Buy at Citigroup), TTEK +2.9% (Cramer makes positive comments on MadMoney), IFX +2.2% (prepares for disposal and deconsolidation of Qimonda; will record a write-down of euro 1 billion; FY08 EBIT guidance remains unchanged), VE +2.2% (still checking), AGU +1.4% (profiled in New America section of IBD)... Analyst upgrades: BRLC +13.2% (upgraded to Outperform at Baird), NCC +4.0% (upgraded to Buy at Deutsche Bank and upgraded to Outperform from Market Perform at Bernstein), BCSI +2.2% (upgraded to Buy at Stifel Nicolaus), LOCM +1.9% (initiated with a Buy at Morgan Joseph).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: OMCL -29.3% (also downgraded to Neutral at Broadpoint), BRKR -17.5% (announces foreign exchange losses in Q1 of 2008), BJS -14.6%, NFLX -13.5% (also removed from Alpha List at Piper and downgraded to Neutral at Credit Suisse), QI -13.2%, AAI -12.3% (also announces intention to offer $65 mln of Convertible Senior Notes due 2015 and to offer 14.25 mln shares of common stock), CSL -11.3%, UNH -10.1%, TLAB -8.6%, PKG -8.0%, AVY -6.4%, NVLS -5.0%, AXE -4.9%, COH -4.6%, VNUS -4.5%, CNI -4.3%, STI -3.9%, FDG -3.6%, CME -3.3%, GENZ -2.8% (announces the FDA has informed co that Myozyme produced at the 160L bioreactor scale and Myozyme produced at the 2000L scale should be classified as two products), CVTI -2.7%, USNA -2.6%, MCD -2.3%, TXN -2.3%, GNTX -1.8%... Select healthcare stocks showing weakness following UNH earnings results: CVH -4.3%, WLP -3.8%, AET -3.7%, WCG -1.4%... Select European financial names trading lower with weakness in overseas trading: RBS -3.9% (takes further write-downs, plans $23.78 bln rights issue - WSJ), BCS -3.5%, ING -2.2%, DB -1.5%... Other news: CIT -12.9% (announces concurrent offerings of common stock and convertible preferred stock, for an aggregate of $1 bln), CNB -6.5% (prices a 38 mln share common stock offering at $8/share), ALO -5.5% (to withdraw and resubmit its New Drug Application for EMBEDA)... Analyst downgrades: VNUS -4.5% (downgraded to Hold at Roth), MDTH -4.2% (downgraded to Hold at Stifel Nicolaus), SAY -3.4% (downgraded to Hold at Stifel Nicolaus), PER -1.8% (downgraded to Hold at Keybanc), AMLN -1.1% (downgraded to Underperform at BMO).